Stocks · Health care · Pharmaceutical Preparations

Verastem, Inc.

VSTM Clue Score56
United States Fiscal year ends December CIK 0001526119 Results filed 14 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Timothy J Barberich
4 Dec 2020
Director
Buy
50,000
$2.17
$108.50K
Timothy J Barberich
15 Mar 2019
Director
Buy
33,000
$3.21
$105.93K
Brian M Stuglik
28 Sep 2018
Director
Buy
600
$7.30
$4.38K
Brian M Stuglik
28 Sep 2018
Director
Buy
100
$7.30
$730.00
Brian M Stuglik
28 Sep 2018
Director
Buy
300
$7.31
$2.19K
Michael Kauffman
28 Sep 2018
Director
Buy
4,000
$7.49
$29.96K
Robert Forrester
28 Sep 2018
President and CEO
Buy
2,000
$7.00
$14.00K
Dan Paterson
28 Sep 2018
Chief Operating Officer
Buy
3,000
$7.00
$21.00K
Joseph M Lobacki
28 Sep 2018
Executive VP & CCO
Buy
3,000
$7.30
$21.90K
Timothy J Barberich
28 Sep 2018
Director
Buy
5,000
$7.31
$36.55K
Dan Paterson
27 Sep 2018
Chief Operating Officer
Buy
1,200
$7.04
$8.45K
Dan Paterson
27 Sep 2018
Chief Operating Officer
Buy
800
$7.01
$5.61K
Robert Forrester
27 Sep 2018
President and CEO
Buy
10,000
$7.00
$70.00K
Robert Forrester
27 Sep 2018
President and CEO
Buy
500
$7.00
$3.50K
Steven H. Bloom
8 Jun 2018
Chief Strategy Officer
Buy
3,000
$5.98
$17.94K
Joseph M Lobacki
8 Jun 2018
Executive VP & CCO
Buy
7,700
$5.79
$44.58K
Timothy J Barberich
5 Dec 2017
Director
Buy
60,538
$3.95
$239.13K
Eric K Rowinsky
5 Sep 2017
Director
Buy indirect
2,000
$3.84
$7.68K
Timothy J Barberich
15 May 2017
Director
Buy
30,000
$2.45
$73.50K

What was left out

Form 4 filings counted 273
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 47
Sales straight out of an exercise 1
Sales at will 114
Transactions with no price 0
Shares from compensation/vesting 10,395,390
Sales filed before the plan box existed 31
History held since 31 Jan 2012